Winton Group’s Evolent Health EVH Stock Holding History

Winton Group’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Buy	26,700 +6,100	+30%	+$23.4K	﹤0.01%	1043
2026 Q1	$47K	Sell	20,600 -1,372	-6%	-$4.35K	﹤0.01%	1064
2025 Q4	$87.9K	Buy	+21,972	New	+$122K	﹤0.01%	879
2025 Q2	–	Sell	-25,981	Closed	-$246K	–	877
2025 Q1	$246K	Buy	+25,981	New	+$262K	0.02%	604
2024 Q1	–	Sell	-21,147	Closed	-$698K	–	687
2023 Q4	$698K	Buy	+21,147	New	+$598K	0.05%	213
2023 Q2	–	Sell	-17,613	Closed	-$572K	–	879
2023 Q1	$572K	Buy	+17,613	New	+$557K	0.03%	643
2022 Q4	–	Sell	-8,486	Closed	-$305K	–	959
2022 Q3	$305K	Buy	+8,486	New	+$299K	0.02%	790
2020 Q1	–	Sell	-124,961	Closed	-$1.13M	–	1436
2019 Q4	$1.13M	Buy	+124,961	New	+$1.02M	0.02%	1018

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Winton Group's EVH Position: Q2 2026 in Review

Winton Group increased its Evolent Health (EVH) stake by 30% in Q2 2026, buying an estimated $23.4K and bringing the position to 26,700 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

Winton Group first reported a position in EVH in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.13M in Q4 2019. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Winton Group held 26,700 shares of Evolent Health worth $145K as of Q2 2026.
Winton Group bought 6,100 Evolent Health shares in Q2 2026, an estimated $23.4K.
Evolent Health made up ﹤0.01% of Winton Group's portfolio in Q2 2026, its #1043 holding.
Winton Group first reported a position in Evolent Health in Q4 2019 and has held it in 8 quarters since.
Winton Group's Evolent Health position peaked at $1.13M in Q4 2019.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Winton Group's 13F filing for Q2 2026, filed 7 Aug 2026.